Medicine

HIV protection through PrEP in cisgender ladies

.RESEARCH STUDY EMPHASIZE.06 August 2024.

A huge randomized controlled test with cisgender women highlights the problems of obedience to an everyday dental preexposure treatment regiment as well as demonstrates that twice-yearly treatment of lenacapavir may sustain efficient HIV prevention levels over 6 months.